Envoy Medical (COCH) vs TELA Bio (TELA)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Envoy Medical (COCH) has outperformed TELA Bio (TELA) over the past year, losing 29.3% versus a loss of 31.4%. Over five years, TELA leads with a -91.7% price change compared with -93.2% for COCH. Envoy Medical is the larger company by market cap ($50.8 million vs $47.4 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | COCH | TELA |
|---|---|---|
| Share price | $0.6576 | $1.05 |
| Market cap | $50.76M | $47.40M |
| 1-day change | +0.61% | -1.87% |
| YTD return | -0.51% | -11.02% |
| 1-year return | -29.29% | -31.37% |
| 5-year return | -93.25% | -91.67% |
| EPS (TTM) | $-0.76 | $-0.77 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $1.02 | $1.56 |
| 52-week low | $0.363 | $0.501 |
| Distance from 52-week high | -35.53% | -32.69% |
| Analyst consensus | strong_buy | strong_buy |
| Avg. price target upside | +229.99% | +98.10% |
| Average volume | 155.47K | 214.83K |
| Shares outstanding | 77.19M | 45.14M |
| Employees | 43 | 218 |
| Sector | Health Care | Health Care |
| Industry | Industrial Specialties | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Envoy Medical
COCH stock →Envoy Medical, Inc., a hearing health company, provides medical technologies across the hearing loss spectrum. The company's medical technologies are designed to shift the paradigm within the hearing industry and bring providers and patients the hearing devices desire.
Health Care · Industrial Specialties · 43 employees
About TELA Bio
TELA stock →TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene, polyglycolic acid, and polylactic-co-glycolic acid designed to be used in laparoscopic and robotic-assisted hernia surgical repairs.
Health Care · Medical/Dental Instruments · 218 employees
COCH vs TELA FAQ
Which is bigger, Envoy Medical or TELA Bio?
Envoy Medical (COCH) is larger, with a market capitalization of $50.76M compared with $47.40M for TELA Bio (TELA).
Which stock has performed better over the past year, COCH or TELA?
COCH returned -29.29% over the past 12 months, compared with -31.37% for TELA (price return, excluding dividends). Past performance does not predict future results.
Are Envoy Medical and TELA Bio in the same industry?
Both are in the Health Care sector, but in different industries: Industrial Specialties for Envoy Medical and Medical/Dental Instruments for TELA Bio.